Neurogene President, CFO Christine Mikail Cvijic sells 4,800 shares for $173,468.40PUBT·Jul 7 at 08:09 PMNGNE-1.88%
Patrick Dolezal Raises Price Target to $65 and Reiterates Buy on NGN-401’s Differentiated Profile and Strong Embolden Study DesignTip Ranks·Jul 7 at 10:45 AMNGNE-1.88%
Neurogene grants inducement stock options for 96,450 shares to new employeesPUBT·Jul 6 at 03:01 PMNGNE-1.88%
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NGNE Stock NewsStockTitan·Jul 6 at 07:01 AMNGNE-1.88%
Neurogene President, CFO Christine Mikail Cvijic sells 4,800 common shares for $166,407.28PUBT·Jul 2 at 05:43 PMNGNE-1.88%
Neurogene says cash runway extends into Q1 2029 after USD 134.8 million stock offeringPUBT·Jul 2 at 05:04 AMNGNE-1.88%
Neurogene Inc. Stock 12‑Month Price Target Raised to $79.62, Implies 153% UpsideTradingView·Jul 1 at 02:20 PMNGNE-1.88%
Neurogene prices USD 125 million follow-on stock offering at USD 30 per sharePUBT·Jul 1 at 06:00 AMNGNE-1.88%
Neurogene Inc. Announces Proposed Public Offering | NGNE Stock NewsStockTitan·Jun 30 at 07:01 AMNGNE-1.88%
